Luiten RM - Search Results

1

The Risk of Keratinocyte Cancer in Vitiligo and the Potential Mechanisms Involved.

Rooker A, Ouwerkerk W, Bekkenk MW, Luiten RM, Bakker WJ. Rooker A, et al. Among authors: luiten rm. J Invest Dermatol. 2024 Feb;144(2):234-242. doi: 10.1016/j.jid.2023.08.012. Epub 2023 Oct 2. J Invest Dermatol. 2024. PMID: 37791932 Free article. Review.

2

Positive correlation between oligonucleotide typing and T-cell recognition of HLA-DP molecules.

de Koster HS, Kenter MJ, D'Amaro J, Luiten RM, Schroeijers WE, Giphart MJ, Termijtelen A. de Koster HS, et al. Among authors: luiten rm. Immunogenetics. 1991;34(1):12-22. doi: 10.1007/BF00212307. Immunogenetics. 1991. PMID: 1713190

3

Therapeutic implications of autoimmune vitiligo T cells.

Oyarbide-Valencia K, van den Boorn JG, Denman CJ, Li M, Carlson JM, Hernandez C, Nishimura MI, Das PK, Luiten RM, Le Poole IC. Oyarbide-Valencia K, et al. Among authors: luiten rm. Autoimmun Rev. 2006 Aug;5(7):486-92. doi: 10.1016/j.autrev.2006.03.012. Epub 2006 May 6. Autoimmun Rev. 2006. PMID: 16920575 Free PMC article. Review.

4

Autoimmune etiology of generalized vitiligo.

Le Poole IC, Luiten RM. Le Poole IC, et al. Among authors: luiten rm. Curr Dir Autoimmun. 2008;10:227-43. doi: 10.1159/000131485. Curr Dir Autoimmun. 2008. PMID: 18460889 Review.

5

A MAGE-A1 peptide is recognized on HLA-B7 human tumors by cytolytic T lymphocytes.

Luiten R, van der Bruggen P. Luiten R, et al. Tissue Antigens. 2000 Feb;55(2):149-52. doi: 10.1034/j.1399-0039.2000.550206.x. Tissue Antigens. 2000. PMID: 10746786

6

Telomerase levels control the lifespan of human T lymphocytes.

Roth A, Yssel H, Pene J, Chavez EA, Schertzer M, Lansdorp PM, Spits H, Luiten RM. Roth A, et al. Among authors: luiten rm. Blood. 2003 Aug 1;102(3):849-57. doi: 10.1182/blood-2002-07-2015. Epub 2003 Apr 10. Blood. 2003. PMID: 12689947 Free article.

7

Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes.

Chaux P, Vantomme V, Stroobant V, Thielemans K, Corthals J, Luiten R, Eggermont AM, Boon T, van der Bruggen P. Chaux P, et al. J Exp Med. 1999 Mar 1;189(5):767-78. doi: 10.1084/jem.189.5.767. J Exp Med. 1999. PMID: 10049940 Free PMC article.

8

Target-specific activation of mast cells by immunoglobulin E reactive with a renal cell carcinoma-associated antigen.

Luiten RM, Fleuren GJ, Warnaar SO, Litvinov SV. Luiten RM, et al. Lab Invest. 1996 Feb;74(2):467-75. Lab Invest. 1996. PMID: 8780164

9

Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.

Chaux P, Luiten R, Demotte N, Vantomme V, Stroobant V, Traversari C, Russo V, Schultz E, Cornelis GR, Boon T, van der Bruggen P. Chaux P, et al. J Immunol. 1999 Sep 1;163(5):2928-36. J Immunol. 1999. PMID: 10453041

10

Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.

van den Boorn JG, Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, Melief CJ, Vyth-Dreese FA, Luiten RM. van den Boorn JG, et al. Among authors: luiten rm. J Invest Dermatol. 2009 Sep;129(9):2220-32. doi: 10.1038/jid.2009.32. Epub 2009 Feb 26. J Invest Dermatol. 2009. PMID: 19242513 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters